Welcome to our dedicated page for Else Nutrition H news (Ticker: BABYF), a resource for investors and traders seeking the latest updates and insights on Else Nutrition H stock.
Else Nutrition Holdings Inc. reports developments tied to its plant-based nutrition business for infants, toddlers, children, and adults. The company’s updates center on whole-food, non-soy, non-dairy products, including toddler nutrition and baby cereal lines made with ingredients such as almonds, buckwheat, and tapioca.
Recurring news themes include U.S. infant-formula regulatory activity, FDA guidance on protein standards, product pipeline positioning, sales milestones, operating and financial progress, shareholder meeting results, governance matters, and capital-structure actions related to convertible funding agreements and equity issuance approvals.
Summary not available.
Else Nutrition Holdings Inc. (BABYF) has announced significant progress on Amazon, now launching a European unified account to market its plant-based baby nutrition products across multiple countries, including the UK, Germany, and France. This move opens access to over 300 million potential customers. The onboarding process has already begun, with plans to launch in early 2022. CEO Hamutal Yitzhak expressed optimism about this venture, anticipating positive performance similar to their success in the US market.
Else Nutrition Holdings Inc. (TSXV: BABY) (OTCQX: BABYF) has received conditional approval to list its common shares and warrants on the Toronto Stock Exchange (TSX), with final approval dependent on meeting customary conditions by January 20, 2022. This move aims to broaden institutional investor reach and improve capital market access. Upon final approval, Else will delist from the TSX Venture Exchange, retaining its trading symbols. The company focuses on plant-based nutrition products and has received accolades for its toddler formula, being a top seller on Amazon.
Else Nutrition Holdings Inc. (TSX-V: BABY, OTCQB: BABYF) announced the issuance of 962,475 stock options to directors, officers, employees, and consultants at a price of CDN$1.65 per share. These options have a five-year exercise period and will vest over a 36-month and 24-month timeline for different portions. With this grant, the total stock options issued by Else amounts to 7,797,925, representing 7.48% of total shares outstanding. This strategic move aligns with the company’s rolling stock option plan to incentivize its workforce.
Else Nutrition Holdings Inc. (BABYF) will host a virtual investor conference on November 18, 2021, at 11 am EST, due to COVID-19 travel restrictions. Registration is open to retail and institutional investors via the company's website. CEO Hamutal Yitzhak expressed enthusiasm for the company's progress and upcoming developments to share with stakeholders. Else Nutrition focuses on plant-based nutrition products for infants and children, with notable achievements including being a top seller on Amazon.
Else Nutrition Holdings Inc. (BABYF) reported strong sales growth in 2021, achieving 10% month-over-month growth on Amazon, with a 60% repeat purchase rate. The company plans to expand its product range from one to over 10 products and enter the Canadian market in Q1 2022. Else is also enhancing its marketing strategies, including Health Care Practitioner (HCP) outreach, and aims to grow retail presence to over 5,000 doors. The introduction of new products like Super Cereal and Ready-to-Drink options is set for 2022.
Else Nutrition Holdings Inc. (BABYF) is set to expand its Plant-Based Nutrition product line through a partnership with U.S.-based online retailer iHerb Inc.
The new products, Plant-Powered Complete Nutrition Shakes for Kids, will be available in chocolate and vanilla flavors on iHerb.com starting November 2021. This collaboration aims to enhance global accessibility to Else’s products for plant-based consumers.
According to CEO Hamutal Yitzhak, the partnership is progressing well, ensuring continued growth in their distribution network.
Else Nutrition Holdings (BABYF) reported robust sales growth on Amazon, averaging 10% month-over-month over the last 6 months, exceeding growth in its category. The company boasts a 62% repurchase rate, significantly higher than the 40-45% average for competing brands. Additionally, 16% of buyers have purchased products 10 times or more. These metrics indicate a strong customer base and increasing subscriptions, positioning Else prominently within the plant-based nutrition market for children.
Else Nutrition Holdings Inc. announced its upcoming investors conference will now be virtual, scheduled for November 18, 2021, at 11 am EST due to COVID-19 restrictions. CEO Hamutal Yitzhak expressed disappointment over the need for a virtual format but highlighted exciting developments to share with investors. Else Nutrition specializes in plant-based nutrition products for infants and children, including a top-selling toddler formula on Amazon. The company remains focused on innovation in the clean and healthy food industry.
Else Nutrition Holdings Inc. announced the successful completion of its first commercial trial run of a patented, Plant-Based Infant Formula for infants aged 0-12 months. The trial took place in the U.S. and utilized innovative technology to produce a cleaner ingredient without compromising nutritional value. CEO Hamutal Yitzhak emphasized the importance of this milestone in providing dairy-free options in the $90 billion global infant formula market, which has been traditionally dominated by dairy and soy products.